Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;16(14):1179-1181.
doi: 10.2217/nnm-2021-0035. Epub 2021 May 11.

How has nanomedical innovation contributed to the COVID-19 vaccine development?

João Paulo Figueiró Longo  1 , Luis Alexandre Muehlmann  2
Affiliations
Editorial

How has nanomedical innovation contributed to the COVID-19 vaccine development?

João Paulo Figueiró Longo et al. Nanomedicine (Lond). 2021 Jun.
No abstract available

Keywords: COVID-19; innovation; lipid nanoparticles; nanomedicine; nanotechnology; vaccine.

PubMed Disclaimer

References

    1. Longo JPF, Mussi S, Azevedo RB, Muehlmann LA. Issues affecting nanomedicines on the way from the bench to the market. J. Mater. Chem. B 8(47), 10681–10685 (2020). - PubMed
    1. Germain M, Caputo F, Metcalfe S et al. Delivering the power of nanomedicine to patients today. J. Control. Release 326, 164–171 (2020). - PMC - PubMed
    1. Park K. The beginning of the end of the nanomedicine hype. J. Control. Release 305, 221–222 (2019). - PubMed
    1. Longo JP F, Lucci CM, Muehlmann LA, Azevedo RB. Nanomedicine for cutaneous tumors – lessons since the successful treatment of the Kaposi sarcoma. Nanomedicine (Lond). 13(23), 2957–2959 (2018). - PubMed
    1. da Rocha MCO, da Silva PB, Radicchi MA et al. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells. J. Nanobiotechnol. 18(1), 1–20 (2020). - PMC - PubMed

Publication types

Substances

LinkOut - more resources